Schall Firm Notifies Investors of Seven Securities Lawsuits
Read, Watch or Listen
Los Angeles — The Schall Law Firm publicly this week notified investors about multiple class action lawsuits alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act and Rule 10b‑5 against seven public companies. The firm identified class periods and filing deadlines for Mereo BioPharma, Varonis, Picard Medical, Ultragenyx, Plug Power, Beyond Meat and Ardent Health, and asked eligible shareholders to contact counsel to pursue lead plaintiff status. Notices referenced SEC-related claims, proposed class dates, and contact details for Brian Schall. The firm stated classes are un-certified pending court action. Based on 7 articles reviewed and supporting research.
Prepared by Christopher Adams and reviewed by editorial team.
Timeline of Events
- June 5, 2023: Mereo BioPharma alleged class period begins.
- August 3, 2023: Ultragenyx alleged class period begins.
- July 18, 2024: Ardent Health alleged class period begins.
- January–September 2025: Class periods for Plug Power (Jan 17), Varonis (Feb 4), Beyond Meat (Feb 27), and Picard Medical (Sept 2) occur and end between October–November 2025.
- February 9, 2026: Schall Law Firm issues investor notices listing class periods and lead-plaintiff deadlines between March and April 2026; classes remain un-certified.
- Articles Published:
- 1
- Right Leaning:
- 0
- Left Leaning:
- 0
- Neutral:
- 1
- Distribution:
- Left 0%, Center 100%, Right 0%
Shareholders who secure lead-plaintiff status, plaintiffs' counsel, and successful claimants may recover losses or obtain monetary relief through settlements or judgments.
Shareholders who incurred losses during the identified class periods experienced financial harm; defendant companies face legal costs, reputational risk, and potential damages if claims succeed.
Coverage of Story:
From Left
No left-leaning sources found for this story.
From Right
No right-leaning sources found for this story.
Comments